Valued at $20.6 billion by market cap, Secaucus, New Jersey-based Quest Diagnostics Incorporated (DGX) provides diagnostic testing services in the U.S. and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine, and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. The healthcare major is gearing up to announce its third-quarter results before the market opens on Tuesday, Oct. 21. Ahead of the event, ...

Accessibility StatementSkip Navigation With the most comprehensive Epic integration by a laboratory provider, collaboration will streamline and strengthen the customer experience for health systems, hospitals, independent providers and their patients SECAUCUS, N.J., Sept. 23, 2025 /PRNewswire/ --Â Quest Diagnostics (NYSE: DGX) and Epic today announced a first-of-its-kind collaboration designed to streamline and improve experiences for healthcare providers and patients that engage Quest for laboratory testin ...